Please login to the form below
BI
This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.
Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
The trial also met its secondary endpoint, demonstrating that BI 1015550 showed acceptable safety and tolerability in IPF patients after 12 weeks. ... Boehringer Ingelheim will begin a phase 3 clinical trial programme to continue investigating if BI
Latest news
-
Sanofi to pay $1.2bn to acquire Amunix and its ‘stealth’ technology
AMX-818 expected to enter the clinic in early 2022. Amunix’s technology offers the potential to overcome challenges that have plagued the adoption of T-Cell Engager bi-specific antibodies
-
US President Biden nominates Robert Califf as FDA commissioner
One possible attraction for the White House is that Califf was easily confirmed in 2016 with strong bi-partisan support in the Senate.
-
Boehringer Ingelheim to boost antibody discovery with partner Twist
Boehringer seems to have been reviewing its partnerships recently. In August, CureVac announced BI had pulled the plug on their long-running partnersip to develop an mRNA cancer vaccine, while in ... disease outbreaks, giving time for the BI’s drug
-
Gilead drug reduces HIV viral reservoir, says researcher
After starting ART, the patients also received bi-weekly doses of either vesatolimod or placebo as an add-on therapy, and then came off therapy while they were monitored for a
-
Shionogi makes buyout play for Tetra ahead of Alzheimer’s readout
Boehringer Ingelheim took a different tack with its Alzheimer’s candidate BI 409306, which targeted PDE9, but that drug also failed mid-stage testing and was unable to show any improvement
More from news
Approximately 4 fully matching, plus 98 partially matching documents found.
Latest Intelligence
-
The ‘Million Hour Challenge’
Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our
-
Is it time we stopped talking about adherence?
attractive and valuable bi-product.
-
Deal Watch September 2016
Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody
-
The human perspective
But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI
-
Deal Watch April 2016
1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest from PMHub
-
Listening to heads AND hearts in healthcare
We talk a lot about using emotions in healthcare communications, but not as much about the business intelligence(BI) behind it. ... What we don’t talk about as much is the business intelligence (BI) behind it.
-
Origins Insights wins the “Best Patient-Centric Approach” award at the BHBIA BOBI Awards 2021
patient voice and the critical role of BI in ensuring this is heard.
-
Havas Lynx Group
AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme.
-
CSL
CSL are a healthcare specialist business intelligence consultancy. We help companies utilise tools like Power BI &Tableau.
-
Visual Numbers Limited
other data to augment intelligence and reveal actionable insights using Tableau and Power BI.
More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
